Albert Renold memorial lecture: Molecular background of nutritionally induced insulin resistance leading to type 2 diabetes - From animal models to humans

International Journal of Experimental Diabetes Research

Volumn 2, Issue 4, 2001, Pages 299-319

  Shafrir, Eleazar ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Acomys cahirinus (spiny mouse); Diacylglycerol phosphate; GLUT4 transporter; Hyperinsulinemia; Insulin receptor; Insulin resistance; Protein kinase B; Protein kinase C; Psammomys obesus (sand rat); Tyrosine kinase

Indexed keywords

DIACYLGLYCEROL; DNA; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR KINASE; LIPID; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; SERINE; THREONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL HYPERPLASIA; CELL LOSS; CELL MEMBRANE; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVATION; ENZYME LOCALIZATION; EPIDEMIC; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTROPHY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; KETOACIDOSIS; KIDNEY CELL; LIPID DIET; METABOLIC CAPACITY; MOLECULAR BIOLOGY; MOUSE; MOUSE STRAIN; MUSCLE; NEGATIVE FEEDBACK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; OBESITY; OVERNUTRITION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

EID: 0035699963     PISSN: 15604284     EISSN: None     Source Type: Journal    
DOI: 10.1155/EDR.2001.299     Document Type: Article

References (105)

1. Definitions for diabetes types: Use and abuse of the concept 'animal models of diabetes mellitus'
2. Defective insulin secretion in the spiny mouse (Acomys cahirinus). Possible value in the study of the pathophysiology of diabetes
3. Overnutrition in spiny mice (Acomys cahirinus): β-cell expansion leading to rupture and overt diabetes on fat-rich diet and protective energywasting elevation in thyroid hormone on sucrose-rich diet
4. Effect of diet-induced obesity on glucose and insulin tolerance of a rodent with a low insulin response (Acomys cahirinus)
5. Intermediary metabolism during the development of obesity and diabetes in the desert rodent Acomys cahirinus
6. Non-insulin-dependent diabetes mellitus - A genetically programmed failure of the beta cell to compensate for insulin resistance
7. The genetics of diabetes susceptibility in mice
8. Analysis of differential survival of syngeneic islets transplanted into hyperglycemic C57BL/6J versus C57BL/KsJ mice
9. Review of the current studies on effect of diet on the glucose tolerance of the sand rat (Psammomys obesus)
10. Achieving predictable model of Type 2 diabetes in sand rats
11. Characterization of stages in the development of obesity-diabetes syndrome in sand rat
12. Psammomys obesus of the Jerusalem colony: A model for nutritionally induced, non-insulin-dependent diabetes
13. Psammomys obesus: Nutritionally induced NIDDM-like syndrome on a 'thrifty gene' background
14. Cellular mechanism of nutritionally induced insulin resistance: The desert rodent Psammomys obesus and other animals in which insulin resistance leads to detrimental outcome
15. Diabetes mellitus in sand rats (Psammomys obesus). Metabolic pattern during development of the diabetic syndrome
16. A cross-sectional and short-term longitudinal characterization of NIDDM in Psammomys obesus
17. Energy intake with respect to the development of diabetes mellitus in Psammomys obesus
18. Chronic exogenous insulin and chronic carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats
19. Beacon: A novel gene involved in regulation of energy balance
20. Effects of beacon administration on energy expenditure and substrate utilization in Psammomys obesus (Israeli Sand rat)
21. Irreversibility of nutritionally induced NIDDM in Psammomys obesus is related to β-cell apoptosis
22. The effect of restricting energy intake on diabetes in Psammomys obesus
23. Diabetic syndrome in sand rats. IV. Morphologic changes in islet tissue
24. Immunocyto-chemical investigation of insulin secretion by pancreatic β-cells in normal and diabetic Psammomys obesus
25. Insulin resistance, β-cell survival, and apoptosis in type 2 diabetes: Animal models and human implications
26. Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes
27. Interaction between genetic and dietary factors determines β-cell function in Psammomys obesus, an animal model of type 2 diabetes
28. Gradual loss of pancreatic beta-cell insulin, glucokinase and GLUT2 glucose transporter immunoreactivities during the time course of nutritionally-induced type 2 diabetes in Psammomys obesus (sand rat)
29. Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat
30. Effects of high glucose on insulin secretion by isolated rat islets and purified β-cells and possible role of glycosylation
31. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function
32. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: Genetic and clinical implications
33. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction
34. Hyperproinsulinemia and insulin deficiency in the diabetic Psammomys obesus
35. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin) diabetes mellitus and in experimental insulin resistance
36. In vivo deactivation of proinsulin action on glucose disposal and hepatic glucose production in normal man
37. Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus
38. Hyperinsulinemia in transgenic mice carrying multiple copies of the human insulin gene
39. Transgenic mice with increased hexosamine flux specifically targeted to β-cells exhibit hyperinsulinemia and peripheral insulin resistance
40. Disease model: Hyperinsulinemia and insulin resistance. Part A - Targeted disruption of insulin signaling or glucose transport. Part B
41. Mechanisms of insulin resistance in experimental hyperinsulinemic dogs
42. Regulation of the insulin receptor kinase by hyperinsulinemia
43. Alterations in tyrosine kinase activity of the insulin receptor produced by in vitro hyperinsulinemia
44. Defective insulin receptor function in down-regulated HepG2 cells
45. Hyperinsulinemia inhibits myocardial protein degradation in patients with cardiovascular disease and insulin resistance
46. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man
47. Patients with insulinoma show insulin resistance in the absence of arterial hypertension
48. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance
49. Cellular mechanism of nutritionally induced insulin resistance in Psammomys obesus. Overexpression of protein kinase Cε in skeletal muscle precedes the onset of hyperinsulinemia and hyperglycemia
50. Nutritionally induced insulin resistance and receptor defect leading to β-cell failure in animal models
51. Modulation of insulin signaling in non-insulin-dependent diabetes mellitus: Significance of altered receptor isoform patterns and mechanisms of glucose-induced receptor modulation
52. Protein kinase C and lipid signaling for sustained cellular responses
53. The efficiency of sand rat metabolism is responsible for development of obesity and diabetes
54. Insulin resistance in the NIDDM model Psammomys obesus in the normoglycemic, normoinsulinemic state
55. Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase
56. Activation of protein kinase Cα inhibits signaling by members of the insulin receptor family
57. Protein kinase C isoforms β1 and β2 inhibit the tyrosine kinase activity of the insulin receptor
58. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling
59. Increased protein kinase C activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats
60. Protein kinase C isoforms α, δ, χ require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells)
61. Rapid and long term effects of protein kinase C on receptor tyrosine kinase phosphorylation and degradation
62. Activation of protein kinase Cα inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1
63. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle - A potential mechanism for insulin resistance in the polycystic ovary syndrome
64. Transcriptional regulation of insulin receptor substrate 1 by protein kinase C
65. Protein kinase C (PKC) epsilon enhances the inhibitory effect of TNF alpha on insulin signaling in HEK293 cells
66. Tumor necrosis factor α inhibits signaling from the insulin receptor
67. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser (307) via distinct pathways
68. Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms β2 and χ
69. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612
70. Identification of Ser-1275 and Ser-1309 as autophosphorvlation sites of the insulin receptor
71. Chronic activation of protein kinase C in soleus muscle and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK) obese/aged, and obese/Zucker rats: A mechanism for inhibiting glycogen synthesis
72. Insulin increases a biochemically distinct pool of diacylglycerol in the rat soleus muscle
73. Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase c activity in cultured aortic smooth muscle cells
74. Triglyceride uptake in muscles in rats
75. Free fatty acid-induced insulin resistance is associated with activation of protein kinase Cχ and alterations in the insulin signaling cascade
76. Intramuscular triglyceride content is increased in IDDM
77. Muscle insulin resistance develops after liver insulin resistance in the high fat fed rat
78. Effects of lipids on blood glucose regulation and insulin action
79. Alterations in the expression and cellular localization of protein kinase C isozymes ε and χ are associated with insulin resistance in skeletal muscle of the high-fat fed rat
80. Skeletal muscle triglyceride levels are inversely related to insulin action
81. Protein-tyrosin phosphatases and the regulation of insulin action
82. Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases
83. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein phosphatase 1B. Possible facilitation by the formation of a ternary conplex with the GRB2 adaptor protein
84. Protein-tyrosine phosphatase 1B interacts with the activated insulin receptor
85. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated siganaling
86. Insulin receptor dephosphorylation by phostyrosine phosphatases obtained from insulin-resistant obese mice
87. Hepatic phosphotyrosine phosphatase activity and its alteration in diabetic rats
88. Insulin resistance is associated with abnormal dephosphorylation of synthetic phospopeptide corresponding to the major autophosphorylation sites of the insulin receptor
89. Increased abyndance of specific skeletal muscle protein-resistant obesity and diabetes mellitus
90. Psammomys obesus (a rodent model of insulin resistance) has a altered regulation and activity of protein-tyrosine phosphatase
91. Molecular and linkage analysis of type-1 protein phosphatase catalytic beta-subunit gene: Lack of evidence for its major role in insulin resistance in Pima Indians
92. Protein tyrosine phosphatase 1B is impaired in skeletal muscle of diabetic Psammomys obesus
93. Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence
94. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats
95. Protein kinase C activation, development of diabetic vascular complications, and role of vitamin E in preventing these abnormalities
96. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells
97. Herbimycin A inhibits protein kinase C in vascular smooth muscle cells
98. Protein kinase C activation and the development of diabetic complications
99. Transgenic mice with inactivation of PKC-χ are protected from lipid-induced defects in insulin action and signaling in skeletal muscle
100. Activation of insulin signal transduction pathway and anti-diabetic activity of small molecule insulin receptor activators
101. Treatment of diabetes with vanadium salts: General overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil
102. Mechanisms of vanadium action: Insulin-mimetic or insulin-enhancing agent?
103. L-Glutamic acid γ-monohydroxamate. A potentiator of vanadium evoked glucose metabolism in vitro and in vivo
104. The role of vanadium in the management of diabetes
105. What if Minkowski had been ageusic? An alternative angle on diabetes